Companies / Cytek Biosciences, Inc. / Activity
Activity — Cytek Biosciences, Inc.
62 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Q1 2026 as of | Prelude Capital Management, LLC 13F manager | Trim | Common stock | $-874 | -200 -1.49% | 13,200 0.01% of shares | low |
| Q3 2025 as of | Prestige Wealth Management Group LLC 13F manager | New | Common stock | $833 | +240 | 240 <0.01% of shares | low |
| Q2 2026 as of | Salomon & Ludwin, LLC 13F manager | Trim | Common stock | $-829 | -181 -39.35% | 279 <0.01% of shares | low |
| Q1 2026 as of | Gsa Capital Partners LLP 13F manager | New | Common stock | $477 | +109K | 109,116 0.08% of shares | low |
| Q1 2026 as of | MAI Capital Management 13F manager | New | Common stock | $341 | +78 | 78 <0.01% of shares | low |
| Q1 2026 as of | Algert Global LLC 13F manager | New | Common stock | $186 | +43K | 42,560 0.03% of shares | low |
| Q1 2026 as of | Commonwealth of Pennsylvania Public School Empls Retrmt Sys 13F manager | Trim | Common stock | $-131 | -30 -0.11% | 27,193 0.02% of shares | low |
| Q1 2026 as of | SG Americas Securities, LLC 13F manager | Trim | Common stock | $-130 | -30K -46.17% | 34,606 0.03% of shares | low |
| Q2 2026 as of | SG Americas Securities, LLC 13F manager | Trim | Common stock | $-96 | -22K -62.27% | 13,056 0.01% of shares | low |
| Q1 2026 as of | Victory Capital Management, Inc. 13F manager | Trim | Common stock | $-31 | -7 -0.04% | 17,621 0.01% of shares | low |
| Q1 2026 as of | Hantz Financial Services, Inc. 13F manager | Add | Common stock | $2 | +298 +103.11% | 587 <0.01% of shares | low |
| Q2 2026 as of | Covestor Ltd 13F manager | Add | Common stock | $0 | +50 +238.10% | 71 <0.01% of shares | low |